isoproterenol has been researched along with n-(1-methylethyl)-1,1,2-trimethylpropylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, WY; Duan, L; Long, CL; Wang, H; Zhang, YF; Zhong, ML; Zhou, HM | 1 |
| Chen, J; Cui, WY; Long, CL; Wang, H; Wang, S; Zhang, H; Zhang, YF | 1 |
2 other study(ies) available for isoproterenol and n-(1-methylethyl)-1,1,2-trimethylpropylamine
| Article | Year |
|---|---|
[Effects of ATP-sensitive potassium channel opener iptakalim against ventricular remodeling and its mechanisms of endothelial protection].
Topics: Animals; Endothelin-1; Hemodynamics; Hydroxyproline; Isoproterenol; KATP Channels; Male; Myocardium; Propylamines; Prostaglandins I; Rats; Rats, Wistar; Ventricular Remodeling | 2013 |
Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells.
Topics: Allyl Compounds; Animals; Dose-Response Relationship, Drug; Endothelial Cells; Glyburide; Heart Failure; Isoproterenol; KATP Channels; Natriuretic Peptide, Brain; Propylamines; Proteomics; Rats; Sulfonylurea Receptors; Ventricular Remodeling | 2017 |